The HPA axis in major depression: classical theories and new developments

Herbert, 2006, Do corticosteroids damage the brain?, J. Neuroendocrinol., 18, 393, 10.1111/j.1365-2826.2006.01429.x Nemeroff, 2005, The neurobiology of depression: inroads to treatment and new drug discovery, J. Clin. Psychiatry, 66, 5 Pariante, 2006, The glucocorticoid receptor: part of the solution or part of the problem?, J. Psychopharmacol., 20, 79, 10.1177/1359786806066063 Sanchez, 2001, Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models, Dev. Psychopathol., 13, 419, 10.1017/S0954579401003029 Heim, 2002, Neurobiology of early life stress: clinical studies, Semin. Clin. Neuropsychiatry, 7, 147, 10.1053/scnp.2002.33127 Heim, 2008, The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma, Biol. Psychiatry, 63, 398, 10.1016/j.biopsych.2007.07.002 Weaver, 2006, Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood, Proc. Natl. Acad. Sci. U. S. A., 103, 3480, 10.1073/pnas.0507526103 Korosi, 2008, The central corticotropin releasing factor system during development and adulthood, Eur. J. Pharmacol., 583, 204, 10.1016/j.ejphar.2007.11.066 Gardner, 2005, Early life experience alters behavior during social defeat: focus on serotonergic systems, Neuroscience, 136, 181, 10.1016/j.neuroscience.2005.07.042 Gardner, K.L. et al. (2006) Early life experience programs gene expression in serotonin neurons. Program no. 562.15. In 2006 Abstracts Viewer/Itinerary Planner [CD ROM]. Washington, DC: Society for Neuroscience Raison, 2006, Cytokines sing the blues: inflammation and the pathogenesis of depression, Trends Immunol., 27, 24, 10.1016/j.it.2005.11.006 O’Brien, 2006, Antidepressant therapy and C-reactive protein levels, Br. J. Psychiatry, 188, 449, 10.1192/bjp.bp.105.011015 Danese, 2007, Childhood maltreatment predicts adult inflammation in a life-course study, Proc. Natl. Acad. Sci. U. S. A., 104, 1319, 10.1073/pnas.0610362104 Pace, 2006, Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress, Am. J. Psychiatry, 163, 1630, 10.1176/appi.ajp.163.9.1630 Caspi, 2003, Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene, Science, 301, 386, 10.1126/science.1083968 Bradley, 2008, Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene, Arch. Gen. Psychiatry, 65, 190, 10.1001/archgenpsychiatry.2007.26 Nemeroff, 2003, Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma, Proc. Natl. Acad. Sci. U. S. A., 100, 14293, 10.1073/pnas.2336126100 Chourbaji, 2008, Mice that under- or overexpress glucocorticoid receptors as models for depression or posttraumatic stress disorder, Prog. Brain Res., 167, 65, 10.1016/S0079-6123(07)67005-8 Miller, 2006, Cytokines, p38 MAP kinase and the pathophysiology of depression, Neuropsychopharmacology, 31, 2089, 10.1038/sj.npp.1301032 Binder, 2004, Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment, Nat. Genet., 36, 1319, 10.1038/ng1479 van Rossum, 2006, Polymorphisms of the glucocorticoid receptor gene and major depression, Biol. Psychiatry, 59, 681, 10.1016/j.biopsych.2006.02.007 Carvalho, L.A. et al. Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not depressed patients. Neuropsychopharmacology (in press) Uhr, 2008, Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression, Neuron, 57, 203, 10.1016/j.neuron.2007.11.017 Karst, 2005, Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone, Proc. Natl. Acad. Sci. U. S. A., 102, 19204, 10.1073/pnas.0507572102 Atkinson, 2008, Corticosteroids mediate fast feedback of the rat hypothalamic-pituitary-adrenal axis via the mineralocorticoid receptor, Am. J. Physiol. Endocrinol. Metab., 294, E1011, 10.1152/ajpendo.00721.2007 Young, 2004, Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder, Neuropsychopharmacology, 29, 1538, 10.1038/sj.npp.1300471 Lightman, 2008, The significance of glucocorticoid pulsatility, Eur. J. Pharmacol., 583, 255, 10.1016/j.ejphar.2007.11.073 Conway-Campbell, 2007, Proteasome-dependent down-regulation of activated nuclear hippocampal glucocorticoid receptors determines dynamic responses to corticosterone, Endocrinology, 148, 5470, 10.1210/en.2007-0585 Young, 2003, Mineralocorticoid receptor function in major depression, Arch. Gen. Psychiatry, 60, 24, 10.1001/archpsyc.60.1.24 Juruena, 2006, Different responses to dexamethasone and prednisolone in the same depressed patients, Psychopharmacology (Berl), 189, 225, 10.1007/s00213-006-0555-4 Bhagwagar, 2003, Increase in concentration of waking salivary cortisol in recovered patients with depression, Am. J. Psychiatry, 160, 1890, 10.1176/appi.ajp.160.10.1890 Bhagwagar, 2005, Increased salivary cortisol after waking in depression, Psychopharmacology (Berl.), 182, 54, 10.1007/s00213-005-0062-z Wetherell, 2006, The four-dimensional stress test: psychological, sympathetic-adrenal-medullary, parasympathetic and hypothalamic-pituitary-adrenal responses following inhalation of 35% CO2, Psychoneuroendocrinology, 31, 736, 10.1016/j.psyneuen.2006.02.005 Spiga, 2007, Effect of the glucocorticoid receptor antagonist Org 34850 on basal and stress-induced corticosterone secretion, J. Neuroendocrinol., 19, 891, 10.1111/j.1365-2826.2007.01605.x John, 2008, Interaction of the glucocorticoid receptor with the chromatin landscape, Mol. Cell, 29, 611, 10.1016/j.molcel.2008.02.010 Ising, 2007, CRH-sub-1 receptor antagonists for the treatment of depression and anxiety, Exp. Clin. Psychopharmacol., 15, 519, 10.1037/1064-1297.15.6.519 Griebel, 2002, Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders, Proc. Natl. Acad. Sci. U. S. A., 99, 6370, 10.1073/pnas.092012099 Flores, 2006, Clinical and biological effects of mifepristone treatment for psychotic depression, Neuropsychopharmacology, 31, 628, 10.1038/sj.npp.1300884